We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Radnet Inc (RDNT) USD0.0001

Sell:$57.00 Buy:$59.00 Change: $0.16 (0.27%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
Change: $0.16 (0.27%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
Change: $0.16 (0.27%)
Market closed |  Prices as at close on 22 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

RadNet, Inc. is a national provider of fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States. It has a network of 366 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.

Contact details

1510 Cotner Ave
United States
+1 (310) 4787808

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$4.32 billion
Shares in issue:
73.88 million
Health Care Services
United States
US dollar

Key personnel

  • Howard Berger
    Chairman of the Board, President, Chief Executive Officer
  • Mark Stolper
    Chief Financial Officer, Executive Vice President
  • Stephen Forthuber
    President, Chief Operating Officer- Eastern Operations
  • Norman Hames
    President, Chief Operating Officer - Western Operations
  • Sham Sokka
    Chief Operating Officer, Chief Technology Officer- Digital Health
  • Mital Patel
    Executive Vice President - Financial Planning and Analysis, Chief Administrative Officer
  • Ranjan Jayanathan
    Executive Vice President, Chief Information Officer
  • David Katz
    Executive Vice President, Chief Legal Officer, Corporate Secretary
  • Gregory Sorensen
    Executive Vice President, Director and Chief Science Officer
  • Michael Murdock
    Executive Vice President - Mergers and Acquisitions

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.